Qnovia
PrivateLast Round
Series B
Dec 10, 2024
Est. Valuation
$300M
Total Funding Raised
$35.25M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Qnovia operates in Healthcare & Life Sciences and is based in Richmond, Virginia. Its latest recorded funding round was a Series B round in December 2024.
Qnovia is a pharmaceutical and medtech company that develops proprietary inhalation device technologies and drug delivery platforms to improve patient outcomes, with an initial focus on smoking cessation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Patient Engagement, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qnovia Comparables
Compare Qnovia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pneuma Respiratory | 86% | |
| Miist Therapeutics | 83% | |
| Koch Industries | 82% |
For institutional investors. Book with your work email.
Qnovia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 10, 2024 | ||||
| Series A | Sep 28, 2022 | ||||
| Seed | Jan 13, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Qnovia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vice Ventures | Series A, Series B |
| Poseidon Asset Management | Seed |
| Compass Rose Asset Management | Series B |
| Gaingels | Series A, Series B, Seed |
| Blue Ledge Capital | Series A, Series B |
| DG Ventures | Series A, Seed |
| Third Lake Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 36% MoM to 3.2K.
- Aug 22, 2026
Monthly visitors increased 76% MoM.
For institutional investors. Book with your work email.
Qnovia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qnovia's valuation, stock price, and market status.
Is Qnovia a public or private company?
Qnovia is a private company.
What is the current stock price of Qnovia?
Qnovia is a private company, so its shares have no public market price. Caplight tracks Qnovia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qnovia worth (valuation)?
Qnovia's valuation is estimated at $300.0M based on funding round data.
Can I buy Qnovia stock?
Qnovia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qnovia's last funding round?
Qnovia's most recent funding round was Series B on December 10, 2024.
Who are the main investors in Qnovia?
Key investors in Qnovia include Vice Ventures, Poseidon Asset Management, Gaingels, Blue Ledge Capital, Evolution VC Partners.
Will Qnovia IPO soon?
No public IPO plans have been announced for Qnovia.
How can I track Qnovia secondary market activity?
Caplight tracks bids, offers, and trades in Qnovia's shares on secondary markets.